Why bladder cancer matters
Bladder cancer is the 5th most common tumour in men and the 7-8th most common tumour women, according to Professor Arnulf Stenzl, Head of the Department of Urology in the… read more.
Bladder cancer is the 5th most common tumour in men and the 7-8th most common tumour women, according to Professor Arnulf Stenzl, Head of the Department of Urology in the… read more.
Current guidelines recommend a repeat TUR (re-TUR) for T1 bladder tumours but this carries risks and could be avoided if a good, complete TUR is done in the… read more.
According to the updated EAU guidelines long-term survival with trimodality bladder preserving treatment (TMT) could be as good as with radical cystectomy (RC), in selected patients. During the… read more.
Trimodality bladder preserving treatment (TMT) for muscle invasive bladder cancer is gaining ground but careful patient selection is essential for success – only 10-20 percent of cases fit… read more.
For many years surgery has been regarded as the gold standard for MIBC but now comparative trials, epidemiological findings and a meta-analysis of trials all show that outcomes… read more.
Intravesical therapy with chemotherapy or BCG is the recommended adjuvant treatment after TURBT to minimise the risk of recurrence. BCG shortages continue and BCG is not suitable for… read more.
The traditional surgical technique for TURBT involves piecemeal removal of the tumour whereas en bloc resection (ERBT) removes the whole tumour in one piece. Professor Jørgen Bjerggaard Jensen (Aarhus, Denmark)… read more.
The introduction of immunotherapy with immune checkpoint inhibitors has improved outcomes in trials. In this video Professor Morgan Roupret explains the current situation regarding immunotherapy and bladder cancer: This session… read more.
Lynch syndrome, an inherited cancer syndrome, has been prominently associated with colorectal cancer but other organs, including the urinary tract can also be affected. As a hereditary condition,… read more.
Patient Safety Learning (PSL) is a charity that works as an independent voice for system-wide change through policy influencing, campaigning and promoting ‘how to’ resources for patient safety… read more.
Helen Hughes, Chief Executive of Patient Safety Learning reflects on what has been learned over the past two years in the field of patient safety and outlines some… read more.
Although only three years old, Patient Safety Learning has already established thriving communities of practice and has run some very successful initiatives including a campaign to improve outpatient… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.